Massive Bio, a leader in AI-enabled patient recruitment and oncology solutions, today announced a collaboration with OpenAI ...

Please provide your email address to receive an email when new articles are posted on . None of the eligible trials received a “good” diversity rating for race and ethnicity. Access-related barriers ...

The US Food and Drug Administration (FDA) is launching a pilot to implement real-time clinical trials (RTCT). While ...

A nationwide analysis of demographic and treatment patterns in admissions for malignant pleural effusions from 2016-2020. Potentially inappropriate medications and their association with frailty, ...

Google Ventures-backed Iterative will now expand its platform into burgeoning therapeutic areas like cardiology and obesity.

Although the genes that affect lipoprotein(a) in European and East Asian populations might vary, the downstream clinical effects that stem from high Lp(a) levels are similar, according to data from ...

The most straightforward way to mitigate liability is to prevent harm in the first place. While it is impossible to eliminate any possibility of injury during clinical research, and therefore ...

Thus, oncology clinical trials often underrepresent older adults, 21 racial/ethnic, 22 and sexual/gender minorities, and patients with concurrent comorbidities, excluding a significant number of ...

Saudi Arabia is emerging as a major growth market for clinical trials in the Middle East, underpinned by strong funding and rapidly developing infrastructure.

Early implementation of real-time clinical trial data sharing aims to reduce delays in safety signal detection and regulatory ...